RIOMET ER Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for RIOMET ER with the United States Patent and Trademark Office. The USPTO has given the RIOMET ER trademark a serial number of 88731302. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 17, 2023. This trademark is owned by Sun Pharmaceutical Industries Limited. The RIOMET ER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations for use by humans in the treatment of diabetes
riomet er

General Information

Serial Number88731302
Word MarkRIOMET ER
Filing DateWednesday, December 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Description of MarkThe mark consists of the words "Riomet ER" with three curved lines under the letter "R".
Goods and ServicesPharmaceutical and medicinal preparations for use by humans in the treatment of diabetes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"ER"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSun Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN
Party NameSun Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Trademark Events

Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2023SOU EXTENSION 5 GRANTED
Thursday, December 15, 2022SOU EXTENSION 5 FILED
Wednesday, January 4, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 15, 2022TEAS EXTENSION RECEIVED
Saturday, June 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 16, 2022SOU EXTENSION 4 GRANTED
Thursday, June 16, 2022SOU EXTENSION 4 FILED
Thursday, June 16, 2022TEAS EXTENSION RECEIVED
Thursday, December 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 14, 2021SOU EXTENSION 3 GRANTED
Tuesday, December 14, 2021SOU EXTENSION 3 FILED
Tuesday, December 14, 2021TEAS EXTENSION RECEIVED
Thursday, June 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 15, 2021SOU EXTENSION 2 GRANTED
Tuesday, June 15, 2021SOU EXTENSION 2 FILED
Tuesday, June 15, 2021TEAS EXTENSION RECEIVED
Thursday, December 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 15, 2020SOU EXTENSION 1 GRANTED
Tuesday, December 15, 2020SOU EXTENSION 1 FILED
Tuesday, December 15, 2020TEAS EXTENSION RECEIVED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 17, 2020ASSIGNED TO EXAMINER
Tuesday, December 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, December 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

riomet treatment diabetes humans preparations medicinal pharmaceutical